Best DRAP Approved Clinical Research Center Lahore | CTU-PMC

CTU-PMC proudly stands as a DRAP approved clinical research center in Lahore, offering internationally compliant, ethically governed, and scientifically robust clinical research services. As medical innovation accelerates globally, the need for credible and regulated research facilities in Pakistan has never been greater. CTU-PMC fulfills this demand by providing a modernized clinical research environment where patient safety, accurate data collection, and ethical responsibility are top priorities.

Our DRAP approval reflects our commitment to following the highest regulatory standards. Every process—from study design to patient enrollment and from data monitoring to reporting—meets the strict guidelines of the Drug Regulatory Authority of Pakistan (DRAP), ICH-GCP, and international medical ethics.

---

A Trusted DRAP Approved Clinical Research Center in Lahore

Being DRAP approved is more than a certification; it is a commitment to delivering clinical research that is trustworthy, transparent, and globally recognized. CTU-PMC’s clinical research operations ensure that pharmaceutical companies, biotech innovators, device manufacturers, and patients receive research outcomes that are scientifically accurate, ethically sound, and fully compliant.

Our Lahore center is equipped with modern infrastructure, experienced investigators, and digital systems that enable seamless execution of Phase II, Phase III, and Phase IV clinical trials. Sponsors worldwide trust CTU-PMC for its professionalism, consistency, and adherence to regulatory excellence.

---

Why DRAP Approval Matters in Clinical Research

The Drug Regulatory Authority of Pakistan plays a central role in ensuring patient safety, medicine quality, and research transparency. Being a DRAP approved clinical research center means:

• All study protocols follow strict regulatory evaluation
• Ethical committees review, monitor, and assess every trial
• Participant safety is always prioritized
• Data collected is accurate, traceable, and reliable
• Trials are conducted only by qualified medical professionals
• Facilities meet regulatory benchmarks
• Full accountability is maintained throughout the study lifecycle

CTU-PMC not only meets these requirements but exceeds them through continuous training, audits, technological upgrades, and adherence to global best practices.

---

State-of-the-Art Research Facilities in Lahore

Our clinical research center in Lahore has been designed to support complex clinical studies with precision and accuracy. CTU-PMC provides:

• Dedicated patient screening and evaluation rooms
• Temperature-controlled drug storage units
• Certified GCP-trained investigators and research staff
• Digital data capture and secure documentation systems
• Emergency care support during trials
• Comfortable patient monitoring and waiting areas
• Partnered laboratory access for rapid diagnostic results
• Advanced pharmacovigilance and safety monitoring tools

These resources ensure that each clinical study is conducted safely, efficiently, and in compliance with DRAP regulations.

---

Experienced Investigators and Certified Research Professionals

The excellence of a DRAP approved clinical research center depends on its people. At CTU-PMC, our team consists of:

• Principal Investigators with extensive clinical trial experience
• Sub-investigators and coordinators trained in ICH-GCP
• Certified research nurses
• Pharmacists managing investigational products
• Data managers ensuring accurate and secure information handling
• Patient support staff and safety officers

This multidisciplinary team ensures smooth trial execution and quality assurance at every stage of the research process.

---

Phase II–IV Trials With Ethical and Scientific Precision

As a DRAP approved clinical research center, CTU-PMC conducts a wide variety of therapeutic area trials, including:

• Oncology
• Cardiology
• Neurology
• Infectious diseases
• Dermatology
• Endocrinology
• Respiratory research
• Gastroenterology

Each study is carefully designed to ensure scientific rigor, patient safety, and regulatory compliance.

---

Why Pharmaceutical Sponsors Choose CTU-PMC

Sponsors from Pakistan and abroad choose our Lahore research center due to our:

✔ Fast and diverse patient recruitment

Lahore’s large population makes enrollment efficient and representative.

✔ DRAP approved operations

Sponsors receive complete assurance of compliance, ethics, and data integrity.

✔ Transparent reporting and real-time monitoring

Every step of the study is documented and communicated with precision.

✔ Secure digital systems

Our research center uses advanced systems for data accuracy and confidentiality.

✔ Commitment to patient safety

Participants receive medical supervision and ethical care throughout the trial.

---

Patient-Centered Approach With Complete Transparency

Participants at CTU-PMC are treated with respect, dignity, and transparency.
Every patient receives:

• Full explanation of study goals and procedures
• Clear informed consent process
• Regular health monitoring
• Access to medical support at all times
• Protection of personal information
• Ethical treatment backed by DRAP and ICH-GCP standards

Our patient-first philosophy ensures high retention rates and reliable study outcomes.

---

Partner With Lahore’s Top DRAP Approved Clinical Research Center

CTU-PMC invites pharmaceutical companies, research sponsors, and volunteers to experience a research center built on trust, safety, and scientific excellence.
We are committed to contributing to healthcare improvement in Pakistan through accurate, ethical, and impactful clinical trials.

Whether you want to conduct a Phase II–IV study, explore collaboration, or join a clinical trial program, CTU-PMC Lahore is ready to support you.

📞 Contact CTU-PMC today to discuss your research needs or participation opportunities.